News
Dr Crystal Mackall Receives IO360 Lifetime Achievement Award for Pioneering Work in T Cell Therapies
The Conference Forum announced that the Immuno-Oncology 360º (IO360º) Summit honored Crystal Mackall, MD, FAAP, FAACR, Stanford University, with the IO360º Lifetime Achievement Award for her ...
Pheast Therapeutics, a private biotechnology company developing novel therapies to unleash the power of macrophages on aggressive, difficult-to-treat cancers, today announced that the first patient ...
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...
A recent study has uncovered a potential breakthrough in treating osteonecrosis of the femoral head (ONFH), a debilitating ...
kuleuven.be Intestinal resident macrophages are at the front line of host defence at the mucosal barrier within the gastrointestinal tract and have long been known to play a crucial role in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results